Baldwin calls on inhaler companies to drop tactic that blocks competitors
U.S. Sen. Tammy Baldwin, D-Wis., wants the four largest inhaler companies to drop a tactic that she says prevents generics from entering the market and lowering costs.
To access this content, you must purchase a Premium membership, or log in if you are a member.
